Report overview
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
This report aims to provide a comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Osteoarthritis Pain. This report contains market size and forecasts of Drugs for Osteoarthritis Pain in global, including the following market information:
Global Drugs for Osteoarthritis Pain Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Osteoarthritis Pain market was valued at US$ 9506 million in 2022 and is projected to reach US$ 13960 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
We surveyed the Drugs for Osteoarthritis Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Osteoarthritis Pain Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, by Type, 2022 (%)
Oral
Injection
External
Global Drugs for Osteoarthritis Pain Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, by Application, 2022 (%)
Medical Care
Personal Care
Global Drugs for Osteoarthritis Pain Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Osteoarthritis Pain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Osteoarthritis Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Osteoarthritis Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Osteoarthritis Pain, market overview.
Chapter 2: Global Drugs for Osteoarthritis Pain market size in revenue.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Osteoarthritis Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
